News

The A-FLUX Reducer System from VahatiCor is designed to treat coronary microvascular dysfunction.

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Impella users need to monitor for blood leaks at the sidearm and hub of the introducer sheath shown below here introducers.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Devi Nair, MD, director of electrophysiology and research at St. Bernards Medical Center and the Arrhythmia Research Group, explains new technology advances in leadless pacing for conduction pacing and Bachmann's bundle pacing.

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.

 

Midjourney ultrasound scanning whole-body ultrasonic CT

Radiologists, meanwhile, took to social media to criticize the endeavor, noting that the generative AI company lacks clinical evidence to back its marketing claims. 

The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR. 

lung cancer screening low-dose CT

While overall lung cancer rates are declining, cases among nonsmoking women are on the rise, puzzling scientists.   

family in supermarket

One of the largest food retailers in the world—and the fourth biggest in this country—got itself into hot water with the U.S. Department of Justice for allegedly cheating on drug prices it charges to federal healthcare programs.

legal liability malpractice artificial intelligence

Tamin Naber, MD, was charged with simple assault for biting a former employee at his medical practice who was suing him for wrongful termination. The incident occurred in November 2025. 

Cardiawave announced the first routine clinical use in Europe of its Valvosoft system since its CE mark regulator clearance in late 2025. It is a noninvasive, high-intensity ultrasound therapy to fragment leaflet calcium in severe symptomatic aortic stenosis, and I is aimed at patients who are not ideal for surgical or transcatheter aortic valve replacement, or who decline surgical intervention.

The new technology was designed for patients who may not be able to undergo SAVR or TAVR.

Cardiologist Michael McMullan explains his surprise about high levels of soft coronary plaque seen on CCTA despite years of intensive statin therapy. #YesCCT

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 

exercise aerobic training fitness resistance training older woman

Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.

brain stethoscope alzheimer's dementia

Researchers in Boston are set to co-lead a long-term study on the aging brain and factors that make individuals more vulnerable to neural injury and cognitive decline. 

Around the web

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.